首页 | 本学科首页   官方微博 | 高级检索  
检索        

5%咪喹莫特乳膏治疗尖锐湿疣的多中心随机双盲平行对照研究
引用本文:刘厚君,涂亚庭,陈兴平,文海泉,谢红付,曹育春.5%咪喹莫特乳膏治疗尖锐湿疣的多中心随机双盲平行对照研究[J].医药导报,2006,25(12):1262-1264.
作者姓名:刘厚君  涂亚庭  陈兴平  文海泉  谢红付  曹育春
作者单位:1. 华中科技大学同济医学院附属协和医院皮肤科,武汉,430022
2. 华中科技大学同济医学院附属同济医院皮肤科,武汉,430030
3. 中南大学湘雅第二医院皮肤科,长沙,410011
4. 中南大学湘雅医院皮肤科,长沙,410008
基金项目:华中科技大学同济医学院生物统计教研室尹平教授完成本文统计学设计与分析
摘    要:目的 了解5%咪喹莫特乳膏治疗肛周和外生殖器尖锐湿疣的临床疗效和安全性。方法 采用随机、双盲、平行对照临床研究方法,共入选尖锐湿疣患者237例,随机分为治疗组119例,给予5%咪喹莫特乳膏适量;对照组118例,给予2.5%氟尿嘧啶乳膏适量;均为每周3次外搽。疗程8周;疣体完全消退者继续随访8周以观察复发率。结果 治疗组和对照组的痊愈率分别为66.4%,66.1%(P〉0.05);有效率分别为85.7%,85.6%(P〉0.05)。治疗组痊愈后复发6例,复发率5.O%;对照组痊愈后复发27例,复发率22.9%(P〈0.05)。治疗组发生不良反应29例。发生率24.4%,时照组发生不良反应44例,发生率37.3%(P〈0.05)。治疗组不良反应主要为给药部位的红斑和糜烂,无系统不良反应。结论 5%咪喹莫特乳膏治疗尖锐湿疣疗效好,安全性好,使用方便。

关 键 词:咪喹莫特  氟尿嘧啶  尖锐湿疣
文章编号:1004-0781(2006)12-1262-03
收稿时间:2005-09-15
修稿时间:2005-10-19

Treatment of Condyloma Acuminatum with 5% Imiquimod Cream: A Multi-centre, Randomized, Double -blind, Parallel -controlled Clinical Trial
LIU Hou-jun,TU Ya-ting,CHEN Xing-ping,WEN Hai-quan,XIE Hong-fu,CAO Yu-chun.Treatment of Condyloma Acuminatum with 5% Imiquimod Cream: A Multi-centre, Randomized, Double -blind, Parallel -controlled Clinical Trial[J].Herald of Medicine,2006,25(12):1262-1264.
Authors:LIU Hou-jun  TU Ya-ting  CHEN Xing-ping  WEN Hai-quan  XIE Hong-fu  CAO Yu-chun
Institution:1. Department of Dermatology, Union Hospital Affiliated with the Tongji Medical College, Huazhon.g University of Science and Technology, Wuhan 430022, China ; 2. Department of Dermatology, Tongji Hospital Affiliated with the Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; 3. Department of Dermatology, the Second Xiangya ttospital, Central South University, Changsha 410011, China; 4. Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China
Abstract:Objective To survey the clinical therapeutic effectiveness and safeness of 5% imiquimod cream in the topical treatment of condyloma acuminatum at the perianal region and external genitalia. Methods A randomized,double blind,multi-centre,parallel-controlled clinical study was carried out.Two hundred thirty seven patients with anogenital condyloma acuminatum enrolled into the trial were randomly divided into 2 groups: the treatment group(n=119) and control group(n=118).Patients of the treatment group and control group were given each 5% imiquimod cream qs and 2.5% 5-fluorouracil cream qs,respectively,administered by topical smearing 3 times a week.The course of treatment in both groups lasted 8 weeks.Patients whose warts had been cleared up completely were followed up for 8 weeks for checking on recurrence rates. Results The cure rates were 66.4% in patients of the treatment group and 66.1% in those of the control group(P>0.05);the effective rates in patients of the treatment group and control group were 86.7% and 85.6%,respectively(P>0.05).6 patients in the treatment group and 27 patients in the control group experienced recurrences of warts after complete recovery,the recurrence rates being 5.0% and 22.4%,respectively(P<0.05).Adverse reactions were encountered in 29 patients(24.4%) of the treatment group and 44 patients(37.3%) of the control group(P<0.05).The major adverse reactions in patients of the treatment group included erythema and erosion in the topical areas where the drug was smeared.There were no systemic adverse reactions in patients of both groups. Conclusion 5% imiquimod cream was shown to be effective,safe and handy in the topical treatment of anogenital condyloma acuminatum.
Keywords:Imiquimod  Fluorouracil  Condyloma aeuminatum
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号